| 疏血通注射液大样本临床使用安全性分析 |
| |
| 引用本文： | 李百强,鲁仲平,方洪壮,苏瑞,孙长海. 疏血通注射液大样本临床使用安全性分析[J]. 中国药物警戒, 2011, 8(10): 592-595 |
| |
| 作者姓名： | 李百强 鲁仲平 方洪壮 苏瑞 孙长海 |
| |
| 作者单位： | 1. 黑龙江省药品不良反应监测中心,黑龙江哈尔滨,150001
2. 佳木斯大学药学院,黑龙江佳木斯,154007 |
| |
| 摘 要： | 目的 了解疏血通注射液临床使用及其安全性.方法 用SPSS 13.0软件,统计分析疏血通注射液安全性监测数据9897份.结果 疏血通注射液用药患者的人数多集中在40岁以上,接近总例数的97％,用药患者男性多于女性.合并用药共涉及16大类药物,无合并用药的仅为93％.疏血通注射液不良反应发生率为0.9％.,不良反应的发生率仅与药物过敏史有关.结论 所涉及的样本数据分析表明,疏血通注射液的有较低的不良反应发生率.
|
| 关 键 词： | 疏血通注射液 安全性 临床使用 |
Analysis of Clinical Use and Safety for large samples of Shuxuetong Injection |
| |
| LI Bai-qang,LU Zhong-ping,FANG Hong-zhuang,SU Rui,SUN Chang-hai. Analysis of Clinical Use and Safety for large samples of Shuxuetong Injection[J]. Chinese JOurnal of Pharmacovigilance, 2011, 8(10): 592-595 |
| |
| Authors: | LI Bai-qang LU Zhong-ping FANG Hong-zhuang SU Rui SUN Chang-hai |
| |
| Affiliation: | LI Bai-qang1 LU Zhong-ping1 FANG Hong-zhuang2 SU Rui2 SUN Chang-hai2(1Heilongjiang Center for ADR Monitoring,Heilongjiang Harbin 150001,China,2College of Pharmacy Jiamusi University,Heilongjiang Jiamusi 154007,China) |
| |
| Abstract: | Objective To understand the clinical use of Shuxuetong injection and its safety.Methods The 9 897 Prospective monitoring data of Shuxuetong injection comeing from 29 hospitals in Heilonjiang province was analyzed by statistical analysis software SPSS13.0.Results The number of Patients with the drugs more concentrated on above 40 years old,closed to the total 97%,and the men were more than women.Combined use of drugs was involving 16 categories,Shuxuetong injection used alone was only 9.3%.The rate of advers... |
| |
| Keywords: | Shuxuetong injection safety clinical use |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
